Drought conditions are making it increasingly difficult for pharmaceutical manufacturers to secure the proper wastewater permits in The Golden State.
The Cold Chain Global Forum has grown from a niche conference to the life science industry's leading temperature-controlled event.
Many call for transparency to combat high drug costs, but outcomes-based pricing is a more realistic solution.
A former FBI agent shares his tips for protecting your products from counterfeit activity.
Pharma EXPO is right around the corner. Discover the key industry trends that directly influenced this year’s conference program and how the event provides a unique opportunity for pharmaceutical professionals to learn from other industries.
Medication nonadherence is a disturbing trend that has a negative effect on patient wellness, hospital costs, and pharmaceutical manufacturer revenue. Drugmakers need to drive improvements in this area and big data, sensor technology, and a new approach to marketing can help.
Meeting the temperature-control needs today’s life science products requires manufacturers to balance regulatory compliance with quality and cost. Discover how the 13th Annual Cold Chain Global Forum can provide you with the insight necessary to succeed.
Pharma EXPO 2015 offers several educational opportunities to choose from, but these three sessions alone could be worth the trip to Vegas.
The emergence of biosimilars in the U.S. will undoubtedly have a marked impact on the pharmaceutical industry, but the market is young and malleable. Pharmaceutical manufacturers currently have a unique opportunity to shape perceptions and use of biosimilars among healthcare providers and their patients.
According to some pharmaceutical industry experts, a pending explosion in biologics coupled with universally inflexible supply chains are creating a perfect storm that demands and overhaul in order to meet demand. Here’s what you can do today.